We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$75M |
| 2 |
Biogen
BIIB
|
+$70.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$60.1M |
| 4 |
Merck
MRK
|
+$54.6M |
| 5 |
Gilead Sciences
GILD
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.1M |
| 2 |
IRBT
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.4M |
| 4 |
Colgate-Palmolive
CL
|
+$14.8M |
| 5 |
Philip Morris
PM
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.26% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Domino's
DPZ
$11.5B
| $1.01M | 0.01% |
3,421
-397
| -10% | -$112K |
|
|
AMTD
602
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1M | 0.01% |
18,935
-1,967
| -9% | -$112K |
|
603
HF Sinclair
DINO
$15.8B
| $996K | 0.01% |
14,244
-3,560
| -20% | -$251K |
|
604
Arbutus Biopharma
ABUS
$875M
| $992K | 0.01% |
+105,000
| New | +$1.04M |
|
605
Take-Two Interactive
TTWO
$44B
| $975K | 0.01% |
7,068
| – | – |
|
606
Agnico Eagle Mines
AEM
$72.9B
| $956K | 0.01% |
27,967
-86,614
| -76% | -$3.37M |
|
607
Expedia Group
EXPE
$32.6B
| $953K | 0.01% |
7,304
+73
| +1% | +$9.48K |
|
608
CarMax
KMX
$8.41B
| $947K | 0.01% |
12,678
-305
| -2% | -$23.3K |
|
|
CALA
609
DELISTED
Calithera Biosciences, Inc
CALA
| $945K | 0.01% |
9,000
| – | – |
|
610
AGNC Investment
AGNC
$12.4B
| $935K | 0.01% |
50,190
-7,691
| -13% | -$147K |
|
611
Fidelity National Financial
FNF
$14B
| $932K | 0.01% |
24,626
| – | – |
|
612
ResMed
RMD
$29.2B
| $930K | 0.01% |
+8,066
| New | +$884K |
|
613
Kimco Realty
KIM
$17.8B
| $921K | 0.01% |
55,017
+7,106
| +15% | +$119K |
|
614
Mercado Libre
MELI
$93.6B
| $920K | 0.01% |
2,703
-700
| -21% | -$237K |
|
615
XPO
XPO
$24.2B
| $918K | 0.01% |
23,241
| – | – |
|
|
AKRX
616
DELISTED
Akorn Inc
AKRX
| $918K | 0.01% |
+70,732
| New | +$1.16M |
|
617
Lennar Class A
LEN
$20.7B
| $915K | 0.01% |
+20,252
| New | +$1.02M |
|
|
VAR
618
DELISTED
Varian Medical Systems, Inc.
VAR
| $911K | 0.01% |
8,138
-290
| -3% | -$32.8K |
|
619
Toll Brothers
TOL
$14.2B
| $906K | 0.01% |
27,425
-237,275
| -90% | -$8.59M |
|
620
The Mosaic Company
MOS
$7.04B
| $905K | 0.01% |
27,877
| – | – |
|
621
Skyworks Solutions
SWKS
$9.28B
| $903K | 0.01% |
9,953
-4,158
| -29% | -$389K |
|
622
Bread Financial
BFH
$4.35B
| $892K | 0.01% |
4,734
| – | – |
|
623
Equity Residential
EQR
$25.4B
| $887K | 0.01% |
13,390
-39,633
| -75% | -$2.62M |
|
|
LPT
624
DELISTED
Liberty Property Trust
LPT
| $883K | 0.01% |
20,893
-24,998
| -54% | -$1.09M |
|
|
LSXMK
625
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $872K | 0.01% |
+26,339
| New | +$935K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2018 Portfolio in Review
As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.
- Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
- Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
- Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
- Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
- Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
- Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.
Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.